MedPath

LEAD CHEMICAL CO., LTD.

🇯🇵Japan
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.leadchem.co.jp

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

7

NMPA:4
SFDA:2
PHILIPPINES:1

Drug Approvals

Loxoprofen Sodium Patches

Product Name
洛索洛芬钠贴剂
Approval Number
国药准字HJ20140639
Approval Date
Jun 14, 2023
NMPA

Loxoprofen Sodium Patches

Product Name
洛索洛芬钠贴剂
Approval Number
国药准字HJ20140638
Approval Date
Jun 14, 2023
NMPA

Loxoprofen Sodium Patches

Product Name
----
Approval Number
国药准字J20150124
Approval Date
Oct 31, 2018
NMPA

Loxoprofen Sodium Patches

Product Name
洛索洛芬钠贴剂
Approval Number
H20181245
Approval Date
Jul 19, 2018
NMPA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)

Phase 2
Completed
Conditions
Delayed Onset Muscle Soreness
Interventions
First Posted Date
2015-11-11
Last Posted Date
2016-10-28
Lead Sponsor
Lead Chemical Co., Ltd.
Target Recruit Count
42
Registration Number
NCT02602353
Locations
🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.